JP Morgan Maintains Neutral on Biomea Fusion, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Eric Joseph maintains a Neutral rating on Biomea Fusion (NASDAQ:BMEA) and raises the price target from $14 to $15.

May 03, 2024 | 3:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Eric Joseph maintains a Neutral rating on Biomea Fusion and raises the price target from $14 to $15.
The increase in price target by JP Morgan suggests a positive outlook on the stock's value, potentially leading to increased investor interest and a short-term price increase. However, the Neutral rating indicates that the stock might not have significant upside potential beyond the new target, tempering expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100